Migraine preventive therapy: selection of appropriate patients and general principles of management. (Q36558665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

Migraine preventive therapy: selection of appropriate patients and general principles of management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Domenico D'Amico

1 reference

14 August 2017

Michel Lanteri-Minet

series ordinal

1 reference

14 August 2017

language of work or name

1 reference

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1147-1157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

Recent findings in headache genetics

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Magnetoencephalographic fields from patients with spontaneous and induced migraine aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Brain stem activation in spontaneous human migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

The scientist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Migraine and probable migraine--results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

The multinational impact of migraine symptoms on healthcare utilisation and work loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Migraine patients experience poorer subjective well-being/quality of life even between attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Measuring the functional status and well-being of patients with migraine headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

The impact of migraine on quality of life in the general population: the GEM study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

A six-item short-form survey for measuring headache impact: the HIT-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Why headache treatment fails

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Migraine throughout the life cycle: treatment through the ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

French guidelines for the diagnosis and management of migraine in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

New guidelines for the management of migraine in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

A self-administered screener for migraine in primary care: The ID Migraine validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Migraine headache disability and health-related quality-of-life: a population-based case-control study from England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Multispecialty consensus on diagnosis and treatment of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Incidence and predictors for chronicity of headache in patients with episodic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Factors associated with the onset and remission of chronic daily headache in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Quality-of-life differences between patients with episodic and transformed migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Evaluation of migraineurs' preferences for naratriptan over conventional first-line agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Ergotamine and dihydroergotamine: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Cardiovascular tolerability and safety of triptans: a review of clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

SF-36 health survey update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Topiramate improves health-related quality of life when used to prevent migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Migraine preventive medication reduces resource utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Target doses and titration schedules for migraine preventive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

The use of triptans in the management of menstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Global trends in migraine care: results from the MAZE survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

Patient perceptions and treatment preferences in migraine management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.8.1147

10.1586/14737175.6.8.1147

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16893343%20AND%20SRC:MED&resulttype=core&format=json